Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Small Molecules Studied
Download: Excel (XLSX), Comma-separated (CSV), Images (Zip file)
HMS LINCS ID | Name | Alternative Names | LINCS ID | Structure Image | PubChem CID |
---|---|---|---|---|---|
10344-1 | Olomoucine II | LSM-6356 | 10067756 | ||
10056-2 | Selumetinib | AZD6244; Array142886 | LSM-1056 | 10127622 | |
10035-2 | Sigma A6730 | KIN001-102; AKT inhibitor VIII; Akt1/2 kinase inhibitor | LSM-1035 | 10196499 | |
10283-1 | XRP44X | AG-G-87906 | LSM-4298 | 10339779 | |
10276-1 | TCS 2312 | LSM-6362 | 11258443 | ||
10268-1 | Nutlin 3a | LSM-6351 | 11433190 | ||
10110-3 | FR180204 | FR 180204; KIN001-230 | LSM-42790 | 11493598 | |
10259-1 | ICRF-193 | LSM-4280 | 115150 | ||
10142-2 | Trametinib | GSK-1120212; GSK1120212; GSK1120212B; JTP-74057 | LSM-1143 | 11707110 | |
10232-2 | Dactolisib | BEZ235; NVP-BEZ235 | LSM-4255 | 11977753 | |
10520-1 | TCS PIM-1 1 | 1235170 | |||
10098-2 | Gefitinib | ZD1839; Iressa | LSM-1098 | 123631 | |
10230-2 | Lestaurtinib | CEP-701 | LSM-1231 | 126565 | |
10264-1 | Methotrexate | Rheumatrex; Trexall; Amethopterin; MTX | LSM-5690 | 126941 | |
10517-1 | Ro 32-0432 | RO-320432 | 127757 | ||
10509-1 | GM6001 | Ilomastat; Galardin; GM-6001 | 132519 | ||
10508-1 | FTase Inhibitor I | B581 | 132887 | ||
10026-3 | PD173074 | LSM-1026 | 1401 | ||
10247-1 | Docetaxel | Taxotere | LSM-6360 | 148124 | |
10277-1 | Temsirolimus | LSM-4295 | 148191 | ||
10236-1 | 17-AAG | Tanespimycin | LSM-43239 | 151069 | |
10013-3 | GSK461364 | GSK461364A | LSM-1013 | 15983966 | |
10265-1 | Pevonedistat | MLN 4924; MLN-4924; MLN4924 | LSM-6263 | 16720766 | |
10097-3 | Erlotinib | OSI-774 | LSM-1097 | 176870 | |
10237-1 | 5-DFUR | 5-FdUR; Doxifluridine | LSM-6359 | 18343 |